FDA.reportPublic FDA data

alendronic acid 70 MG Effervescent Oral Tablet

RxCUI
1248077
RxNorm name
alendronic acid 70 MG Effervescent Oral Tablet
Display name
alendronic acid 70 MG Effervescent Oral Tablet
Full name
alendronic acid 70 MG Effervescent Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BinostoALENDRONATE SODIUMRadius Health, Inc.09765234-01bc-40f7-b9bb-c167056f39092026-02-06Warnings, Adverse reactionsExact identifier
rxcui: 1248077

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
b278a11a-b8d7-49f3-9b38-29b67c4c417ealendronic acid 70 MG Effervescent Oral TabletSCD23BINOSTO (alendronate sodium) effervescent tablets for oral solution These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520231220
b278a11a-b8d7-49f3-9b38-29b67c4c417ealendronic acid (as alendronate sodium) 70 MG Effervescent Oral TabletSY23BINOSTO (alendronate sodium) effervescent tablets for oral solution These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520231220
b278a11a-b8d7-49f3-9b38-29b67c4c417ealendronate sodium 70 MG Effervescent Oral TabletPSN23BINOSTO (alendronate sodium) effervescent tablets for oral solution These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520231220
ad670460-141b-e481-f713-7aed9485de8dalendronate sodium 70 MG Effervescent Oral TabletPSN9These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520181022
ad670460-141b-e481-f713-7aed9485de8dalendronic acid 70 MG Effervescent Oral TabletSCD9These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520181022
ad670460-141b-e481-f713-7aed9485de8dalendronic acid (as alendronate sodium) 70 MG Effervescent Oral TabletSY9These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520181022
09765234-01bc-40f7-b9bb-c167056f3909alendronic acid (as alendronate sodium) 70 MG Effervescent Oral TabletSY6These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520260206
09765234-01bc-40f7-b9bb-c167056f3909alendronic acid 70 MG Effervescent Oral TabletSCD6These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520260206
09765234-01bc-40f7-b9bb-c167056f3909alendronate sodium 70 MG Effervescent Oral TabletPSN6These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520260206